Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose IVIG During Pregnancy for Prevention of Recurrent Neonatal Hemochromatosis
jRCT2031220624Recruiting
- Start
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of immune globulin in neonatal hemochromatosis (NH). Started Jun 2018; status: recruiting.
02
Drugs
immune globulin
03
Conditions
neonatal hemochromatosis (NH)
Beyond the preview
Go deeper on jRCT2031220624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220624.